Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heikkilä, R
Right arrow Articles by Palosuo, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heikkilä, R
Right arrow Articles by Palosuo, T
Ann Rheum Dis 1998;57:281-285 ( May )

Extended reports

Serum androgen-anabolic hormones and the risk of rheumatoid arthritis R Heikkilä,a K Aho,b M Heliövaara,b P Knekt,b A Reunanen,b A Aromaa,b A Leino,c T Palosuob

a Kanta-Häme Central Hospital, Hämeenlinna, Finland, b National Public Health Institute, Helsinki, Finland, c Research and Development Centre, Social Insurance Institution, Turku, Finland

Correspondence to: Dr R Heikkilä, Kanta-Häme Central Hospital, Fin-13530, Hämeenlinna, Finland.

Accepted for publication 17 March 1998

OBJECTIVE---It has been hypothesised, mainly on the basis of indirect evidence, that low serum concentrations of androgen-anabolic hormones would play a causal part in the aetiology of rheumatoid arthritis (RA).
METHODS---A case-control study was nested with a Finnish cohort of 19 072 adults who had neither arthritis nor a history of it at the baseline examination during 1973-1977. Pre-illness serum specimens for the assay of testosterone and dehydroepiandrosterone sulphate (DHEAS) were available from 116 cases who had developed RA by late 1989. Three controls per each incident case were individually matched for sex, age, and municipality.
RESULTS---The mean testosterone concentration was 1.4 nmol/l in those 84 women who developed RA and 1.4 nmol/l in their controls; the corresponding figures for DHEAS were 5.2 µmol/l and 5.5 µmol/l, respectively. Mean testosterone concentration in the 32 male cases was 26.1 nmol/l and 26.4 nmol/l in their controls; the corresponding figures for DHEAS were 11.2 µmol/l and 10.1 µmol/l, respectively. Analysis by subgroups (rheumatoid factor positive and negative disease, premenopausal and postmenopausal women) and by hormone distributions showed no differences.
CONCLUSION---The findings are not in line with the contention that low concentrations of testosterone and DHEAS play a part in the aetiology of RA.

Keywords: rheumatoid arthritis; epidemiology; testosterone; dehydroepiandrosterone sulphate

© 1998 by Annals of the Rheumatic Diseases


This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
M.-K. Koivula, M. Heliovaara, J. Ramberg, P. Knekt, H. Rissanen, T. Palosuo, and J. Risteli
Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis
Ann Rheum Dis, November 1, 2007; 66(11): 1450 - 1455.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
A. T. MASI, R. T. CHATTERTON, J. C. ALDAG, and R. L. MALAMET
Perspectives on the Relationship of Adrenal Steroids to Rheumatoid Arthritis
Ann. N.Y. Acad. Sci., June 1, 2002; 966(1): 1 - 12.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. A. P. DA SILVA
Relationships between Glucocorticoids and Gonadal Steroids in Rheumatoid Arthritis
Ann. N.Y. Acad. Sci., June 1, 2002; 966(1): 158 - 165.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
P. H. Dessein, A. E. Stanwix, Z. Moomal, D. Symmons, and B. Harrison
Rheumatoid arthritis and cardiovascular disease may share similar risk factors
Rheumatology, June 1, 2001; 40(6): 703 - 704.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
D. Symmons and B. Harrison
Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. I. Risk factors for the development of inflammatory polyarthritis and rheumatoid arthritis
Rheumatology, August 1, 2000; 39(8): 835 - 843.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
B. Larsen, C. A. King, M. Simms, and V. M. Skanes
Major histocompatibility complex phenotypes influence serum testosterone concentration
Rheumatology, July 1, 2000; 39(7): 758 - 763.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. S. Kanik, G. P. Chrousos, H. R. Schumacher, M. L. Crane, C. H. Yarboro, and R. L. Wilder
Adrenocorticotropin, Glucocorticoid, and Androgen Secretion in Patients with New Onset Synovitis/Rheumatoid Arthritis: Relations with Indices of Inflammation
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1461 - 1466.
[Abstract] [Full Text]

Home page
 Ann. N. Y. Acad. Sci.Home page
E. J. GILTAY, D. VAN SCHAARDENBURG, L. J. G. GOOREN, and B. A. C. DIJKMANS
Dehydroepiandrosterone Sulfate in Patients with Rheumatoid Arthritis
Ann. N.Y. Acad. Sci., June 22, 1999; 876(1): 152 - 154.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 BMJ Publishing Group Ltd & European League Against Rheumatism